-
Vadimezan (also
known as or ASA404 and
dimethylxanthenone acetic acid or DMXAA) is a tumor-vascular
disrupting agent (tumor-VDA) that
attacks the blood...
-
combretastatin A-4
disodium phosphate (CA4P), ZD6126, AVE8062, Oxi 4503
vadimezan (ASA404)
Phase II : ZD6126, CA4P,
plinabulin (NPI-2358)
Phase III : DMXAA...
- V-Cillin V-Cillin K
vabicaserin (INN)
Vablys Vabomere Vaborem Vabysmo vadimezan (USAN, INN)
vadocaine (INN)
Vafseo Vagifem Vagilia Vagistat-1 Vagigard...
- Leach, J.; et al. (2010). "Phase II
Study on the
Addition of ASA404 (
Vadimezan; 5,6-Dimethylxanthenone-4-Acetic Acid) to
Docetaxel in CRMPC". Clinical...
- vaccines,
cancer and
viral infection. At Harvard, she
studied the drug
Vadimezan (DMXAA), an
activator of the
stimulator of
interferon genes (STING) pathway...
